BiFeS vs. iPACK in Postoperative Knee Arthroplasty Analgesia

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorAmasya University

About this trial

The Biceps Femoris Short Head (BiFeS) block is a new fascial plane block technique targeting the sensory innervation of the posterolateral capsule of the knee while preserving motor function. The aim of this study is to evaluate the postoperative analgesic efficacy of the BiFeS block combined with the adductor canal block (ACB) in patients undergoing total knee arthroplasty, compared to ACB + iPACK block. The study is planned as a prospective, randomized, double-blind, parallel two-group trial. Patients will be randomized in a 1:1 ratio to receive ACB + iPACK (Group A) or ACB + BiFeS (Group B). Postoperative pain scores (VAS), opioid consumption, early mobilization, and quality of recovery (QoR-15) outcomes will be compared.

Eligibility criteria

Qualifiers

Scheduled for unilateral total knee arthroplasty

Classified as ASA physical status I-III

Disqualifiers

Scheduled for revision arthroplasty or bilateral surgery

Allergy to local anesthetics or contraindication to regional blocks

Neurological disorders, peripheral neuropathy, or conditions affecting lower extremity muscle strength

Coagulopathy or receiving anticoagulant therapy

Trial design

Treatments tested in this trial

  • Biceps Femoris Short Head Block (BiFeS)
  • Infiltration Between The Popliteal Artery and The Capsule of The Knee
  • Adductor Canal Block

Treatment groups

88 Participants
are divided into 2 treatment groups

Sponsors and collaborators